Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Circulation: Arrhythmia and Electrophysiology. 2008;1:62-73
doi: 10.1161/CIRCEP.107.754564
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nattel, S.
Right arrow Articles by Dobrev, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nattel, S.
Right arrow Articles by Dobrev, D.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Arrythmias-basic studies
Right arrow Ion channels/membrane transport

Basic Science for the Clinical Electrophysiologist

Atrial Remodeling and Atrial Fibrillation

Mechanisms and Implications

Stanley Nattel, MD; Brett Burstein, BSc and Dobromir Dobrev, MD

From the Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal (S.N., B.B.), Montreal, Quebec, Canada; Department of Pharmacology and Therapeutics, McGill University (S.N., B.B.), Montreal, Quebec, Canada; and Department of Pharmacology and Toxicology (D.D.), Dresden University of Technology, Dresden, Germany.

Correspondence to Stanley Nattel, Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec, Canada H1T 1C8. E-mail stanley.nattel@icm-mhi.org

Key Words: antiarrhythmia agents • arrhythmia • electrophysiology • ion channels • remodeling


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


    Introduction
 
Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. It can occur at any age but is very rare in children and becomes extremely common in the elderly, with a prevalence approaching 20% in patients >85 years of age.1 AF is associated with a wide range of potential complications and contributes significantly to population morbidity and mortality. Present therapeutic approaches to AF have major limitations, including limited efficacy and significant adverse effect liability. These limitations have inspired substantial efforts to improve our understanding of the mechanisms underlying AF, with the premise that improved mechanistic insights will lead to innovative and improved therapeutic approaches.2

Our understanding of AF pathophysiology has advanced significantly over the past 10 to 15 years through an increased awareness of the role of "atrial remodeling." Any persistent change in atrial structure or function constitutes atrial remodeling. Many forms of atrial remodeling promote the occurrence or maintenance of AF by acting on the fundamental arrhythmia mechanisms illustrated in Figure 1. Both rapid ectopic firing and reentry can maintain AF. Reentry requires a suitable vulnerable substrate, as well as a trigger that acts on the substrate to initiate reentry. Ectopic firing contributes to reentry by providing triggers for reentry induction. Atrial remodeling has the potential to increase the likelihood of ectopic or reentrant activity through a multitude of potential mechanisms. This article reviews the types of atrial remodeling, their underlying pathophysiology, the molecular basis of their occurrence, and finally, their potential therapeutic significance.


Figure Removed (Available Only in the Full Text)
View larger version (12K):



 
Figure 1. General . . . [Full Text of this Article]

 



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
A. Sridhar, Y. Nishijima, D. Terentyev, M. Khan, R. Terentyeva, R. L. Hamlin, T. Nakayama, S. Gyorke, A. J. Cardounel, and C. A. Carnes
Chronic heart failure and the substrate for atrial fibrillation
Cardiovasc Res, July 17, 2009; (2009) cvp216v2.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. Qi, J. Xiao, Y. Zhang, J. Li, Y. Liu, P. Li, L. Liang, B. Jiang, W. Wen, C. Zhao, et al.
Effects of Potassium Channel Blockers on Changes in Refractoriness of Atrial Cardiomyocytes Induced by Stretch
Experimental Biology and Medicine, July 1, 2009; 234(7): 779 - 784.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Dobrev
Ion Channel Portrait of the Human Sinus Node: Useful for a Better Understanding of Sinus Node Function and Dysfunction in Humans?
Circulation, March 31, 2009; 119(12): 1556 - 1558.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Shiroshita-Takeshita, H. Mitamura, S. Ogawa, and S. Nattel
Rate-dependence of atrial tachycardia effects on atrial refractoriness and atrial fibrillation maintenance
Cardiovasc Res, January 1, 2009; 81(1): 90 - 97.
[Abstract] [Full Text] [PDF]